ATE269057T1 - Arzneizubereitungen und deren herstellungsverfahren - Google Patents

Arzneizubereitungen und deren herstellungsverfahren

Info

Publication number
ATE269057T1
ATE269057T1 AT01917326T AT01917326T ATE269057T1 AT E269057 T1 ATE269057 T1 AT E269057T1 AT 01917326 T AT01917326 T AT 01917326T AT 01917326 T AT01917326 T AT 01917326T AT E269057 T1 ATE269057 T1 AT E269057T1
Authority
AT
Austria
Prior art keywords
particles
production process
emulsion
medicinal preparations
active substance
Prior art date
Application number
AT01917326T
Other languages
English (en)
Inventor
John Nicholas Staniforth
Michael John Tobyn
Cheryl Julia Clinch
Robert Price
Original Assignee
Vectura Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9889294&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE269057(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vectura Ltd filed Critical Vectura Ltd
Application granted granted Critical
Publication of ATE269057T1 publication Critical patent/ATE269057T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Colloid Chemistry (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT01917326T 2000-04-05 2001-04-05 Arzneizubereitungen und deren herstellungsverfahren ATE269057T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0008411.1A GB0008411D0 (en) 2000-04-05 2000-04-05 Pharmaceutical preparations and their manufacture
PCT/GB2001/001562 WO2001074332A1 (en) 2000-04-05 2001-04-05 Pharmaceutical preparations and their manufacture

Publications (1)

Publication Number Publication Date
ATE269057T1 true ATE269057T1 (de) 2004-07-15

Family

ID=9889294

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01917326T ATE269057T1 (de) 2000-04-05 2001-04-05 Arzneizubereitungen und deren herstellungsverfahren

Country Status (22)

Country Link
US (2) US20030157182A1 (de)
EP (1) EP1267833B1 (de)
JP (1) JP2003528907A (de)
KR (1) KR20030011816A (de)
CN (1) CN1420764A (de)
AT (1) ATE269057T1 (de)
AU (1) AU4440601A (de)
BR (1) BR0109802A (de)
CA (1) CA2404367A1 (de)
DE (1) DE60103865T2 (de)
DK (1) DK1267833T3 (de)
ES (1) ES2218402T3 (de)
GB (1) GB0008411D0 (de)
HU (1) HUP0300334A3 (de)
IL (1) IL152074A0 (de)
MX (1) MXPA02009797A (de)
NO (1) NO20024737L (de)
PL (1) PL357808A1 (de)
PT (1) PT1267833E (de)
TR (1) TR200401567T4 (de)
WO (1) WO2001074332A1 (de)
ZA (1) ZA200207508B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004073827A1 (en) * 2003-02-21 2004-09-02 The University Of Bath Process for the production of particles
GB0425758D0 (en) 2004-11-23 2004-12-22 Vectura Ltd Preparation of pharmaceutical compositions
GB0426301D0 (en) * 2004-11-30 2004-12-29 Vectura Ltd Pharmaceutical formulations
CN101272848B (zh) * 2005-07-28 2013-03-13 Isp投资有限公司 改进喷雾干燥的粉末和颗粒材料性质的方法，以及由此生产的产品
JP2007326083A (ja) * 2006-06-09 2007-12-20 Fujifilm Corp 固体微粒子及びその製造方法
US20080085315A1 (en) * 2006-10-10 2008-04-10 John Alfred Doney Amorphous ezetimibe and the production thereof
US9079149B2 (en) * 2006-11-14 2015-07-14 Basf Aktiengesellschaft Method for production of a minisuspoemulsion or suspension of sub-micron core/shell particles
US20080152717A1 (en) * 2006-12-14 2008-06-26 Isp Investments, Inc. Amorphous valsartan and the production thereof
US8613946B2 (en) * 2006-12-21 2013-12-24 Isp Investment Inc. Carotenoids of enhanced bioavailability
US10189957B2 (en) * 2007-01-26 2019-01-29 Isp Investments Llc Formulation process method to produce spray dried products
US20080181961A1 (en) * 2007-01-26 2008-07-31 Isp Investments, Inc. Amorphous oxcarbazepine and the production thereof
PL220269B1 (pl) 2008-04-21 2015-09-30 Przedsiębiorstwo Produkcji Farmaceutycznej Hasco Lek Spółka Akcyjna Kompozytowy nośnik leków proszkowych, sposób wytwarzania nośnika leków oraz urządzenie do wytwarzania cząstek nośnika kompozytowego
CN102149437B (zh) 2008-07-18 2017-02-15 普罗索尼克斯有限公司 用于提高氟替卡松颗粒结晶度的方法
CN102107127B (zh) * 2011-01-11 2015-04-22 西安蓝晓科技新材料股份有限公司 一种粉体造粒技术
CA2841367A1 (en) * 2011-07-15 2013-01-24 Eupharma Pty Ltd Oral compositions comprising an antacid, an anaesthetic and an inorganic matrix comprising silicon dioxide and titanium dioxide
PT107433B (pt) * 2014-01-28 2018-12-04 Hovione Farm S A Processo de redução e controlo do tamanho de partícula
CN109890225B (zh) * 2016-11-10 2022-05-27 日本烟草产业株式会社 球状的粉末凝聚体及其制造方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2608988B1 (fr) * 1986-12-31 1991-01-11 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanoparticules
SE464743B (sv) * 1989-06-21 1991-06-10 Ytkemiska Inst Foerfarande foer framstaellning av laekemedelspartiklar
FR2694895B1 (fr) * 1992-08-20 1994-11-10 Coletica Procédé de fabrication de microparticules en émulsion par modification de la composition chimique de la phase dispersée après émulsification.
EP2283821A1 (de) * 1993-11-19 2011-02-16 Alkermes, Inc. Herstellung biodegradierbarer Mikroteilchen, die ein biologisch aktives Mittel enthalten
US6214331B1 (en) * 1995-06-06 2001-04-10 C. R. Bard, Inc. Process for the preparation of aqueous dispersions of particles of water-soluble polymers and the particles obtained
DE19617085A1 (de) * 1996-04-29 1997-10-30 Bayer Ag Verfahren zur Herstellung von feinstteiligen Kristallisationsprodukten
US5792477A (en) * 1996-05-07 1998-08-11 Alkermes Controlled Therapeutics, Inc. Ii Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent
GB9700624D0 (en) * 1997-01-14 1997-03-05 Danbiosyst Uk Drug delivery composition
US6150505A (en) 1997-09-19 2000-11-21 Hadasit Medical Research Services & Development Ltd. Fibrin microbeads prepared from fibrinogen, thrombin and factor XIII
US6565885B1 (en) * 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions

Also Published As

Publication number Publication date
PL357808A1 (en) 2004-07-26
IL152074A0 (en) 2003-05-29
HUP0300334A3 (en) 2005-04-28
US20030157182A1 (en) 2003-08-21
NO20024737L (no) 2002-11-18
ES2218402T3 (es) 2004-11-16
US20100015234A1 (en) 2010-01-21
CA2404367A1 (en) 2001-10-11
TR200401567T4 (tr) 2004-08-23
DK1267833T3 (da) 2004-07-19
EP1267833B1 (de) 2004-06-16
MXPA02009797A (es) 2004-09-13
WO2001074332A1 (en) 2001-10-11
AU4440601A (en) 2001-10-15
KR20030011816A (ko) 2003-02-11
PT1267833E (pt) 2004-11-30
DE60103865D1 (de) 2004-07-22
GB0008411D0 (en) 2000-05-24
EP1267833A1 (de) 2003-01-02
ZA200207508B (en) 2003-09-19
NO20024737D0 (no) 2002-10-02
JP2003528907A (ja) 2003-09-30
DE60103865T2 (de) 2004-10-28
HUP0300334A2 (hu) 2003-09-29
BR0109802A (pt) 2003-01-21
CN1420764A (zh) 2003-05-28

Similar Documents

Publication Publication Date Title
DE60103865D1 (de) Arzneizubereitungen und deren herstellungsverfahren
DK0737065T3 (da) Fremgangsmåde til fremstilling af faste farmaceutiske doseringsformer
ATE77946T1 (de) Injizierbares langwirkendes mikroteilchenpr|parat zur verabreichung entzuendungshemmender mittel.
DK0744941T3 (da) Fremgangsmåde til fremstilling af findelte farmaceutiske formuleringer
DK0737064T3 (da) Fremgangsmåde til fremstilling af faste farmaceutiske doseringsformer af hydrofobe stoffer
MA26508A1 (fr) Formulations pharmaceutiques contenant du variconazole, et procede pour leur preparation.
ES2157975T3 (es) Soluciones farmaceuticas con solubilidad mejorada.
CY1112338T1 (el) Μεθοδος παρασκευης σωματιδιων για χρηση σε φαρμακευτικη συνθεση
TR199901669T2 (xx) Erkeklerdeki ereksiyon probleminin tedavisi i�in gerekli dozaj �ekilleri ve metod.
ES2126536A1 (es) "preparado farmaceutico para administracion intranasal"y procedimiento para su produccion.
ATE327156T1 (de) Verfahren und vorrichtung zur herstellung von kapseln
NO934315D0 (no) Farmas!ytisk b{rer
NO20002788D0 (no) Nye forbindelser
ES2187201T3 (es) Empleo de esteroles y de esterolesteres a nanoescala.
ATE245171T1 (de) Methyliden-malonat nanopartikel, verfahren zu deren herstellung, und diese enthaltende pharmazeutische praeparate
AU8009998A (en) Method for producing orally administered, solid pharmaceutical products with controlled release of the active substance
AR011080A1 (es) Composicion en polvo seco, proceso para su preparacion y uso de dicha composicion para la fabricacion del medicamento
WO2002043702A3 (en) Pharmaceutical compositions for inhalation
MXPA04005767A (es) Formacion previa para hacer tabletas de mezclas naturales de estrogenos conjugados.
ATE442852T1 (de) Trimetazidine enthaltendes arzneimittel mit verzögerter wirkstoffabgabe und verfahren zur herstellung
SE8800080L (sv) Laekemedelskomposition
WO2000003724A1 (en) Preparations for immunotherapy for cancer having bacterial somatic constituent as the active ingredient
FR2803848B1 (fr) Nouveaux derives de benzenesulfonamide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2827287B1 (fr) Nouveaux derives de benzene sulfonamide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MA27407A1 (fr) Nouveaux derives de 2,3-dihydro-4(1h)-pyridinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1267833

Country of ref document: EP